Aprogen Medicines Inc.
007460.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
113
Cost of Revenue
86
Gross Profit
26
Gross Margin
23.3%
Operating Income
-65
Operating Margin
-57.8%
Net Income
-44
Net Margin
-38.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-55
EBITDA Margin
-48.9%
2023
12/31/2023
Revenue
113
Cost of Revenue
86
Gross Profit
27
Gross Margin
23.8%
Operating Income
-67
Operating Margin
-59.0%
Net Income
-42
Net Margin
-36.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-49
EBITDA Margin
-43.5%
2022
12/31/2022
Revenue
59
Cost of Revenue
54
Gross Profit
5
Gross Margin
7.9%
Operating Income
-86
Operating Margin
-146.0%
Net Income
-87
Net Margin
-148.2%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-57
EBITDA Margin
-97.2%
2021
12/31/2021
Revenue
106
Cost of Revenue
82
Gross Profit
23
Gross Margin
22.1%
Operating Income
-2
Operating Margin
-1.9%
Net Income
-9
Net Margin
-8.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-53
EBITDA Margin
-49.9%
2020
12/31/2020
Revenue
95
Cost of Revenue
70
Gross Profit
26
Gross Margin
27.1%
Operating Income
4
Operating Margin
4.4%
Net Income
-25
Net Margin
-25.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-15
EBITDA Margin
-16.0%